2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.453

Change

-0.05 (-0.68)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.01 (+0.04%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.21%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.14 (+0.27%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.58 (-0.26%)

USD 80.38B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.89% 71% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.89% 70% C- 70% C-
Trailing 12 Months  
Capital Gain 28.90% 78% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.90% 77% C+ 77% C+
Trailing 5 Years  
Capital Gain 37.23% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.23% 57% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.73% 59% D- 58% F
Dividend Return 7.73% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.45% 33% F 45% F
Risk Adjusted Return 50.05% 47% F 53% F
Market Capitalization 0.50B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.